Find information on thousands of medical conditions and prescription drugs.

Portal vein thrombosis

Portal vein thrombosis is a form of venous thrombosis affecting the portal vein, which can lead to portal hypertension and reduction in the blood supply to the liver.

Causes can include pancreatitis, cirrhosis, diverticulitis, and cholangiocarcinoma.

Treatments include anticoagulants, shunts, bypass surgery, and transplants.

Home
Diseases
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Arthritis
Arthritis
Bubonic plague
Hypokalemia
Pachydermoperiostosis
Pachygyria
Pacman syndrome
Paget's disease of bone
Paget's disease of the...
Palmoplantar Keratoderma
Pancreas divisum
Pancreatic cancer
Panhypopituitarism
Panic disorder
Panniculitis
Panophobia
Panthophobia
Papilledema
Paraganglioma
Paramyotonia congenita
Paraphilia
Paraplegia
Parapsoriasis
Parasitophobia
Parkinson's disease
Parkinson's disease
Parkinsonism
Paroxysmal nocturnal...
Patau syndrome
Patent ductus arteriosus
Pathophobia
Patterson...
Pediculosis
Pelizaeus-Merzbacher disease
Pelvic inflammatory disease
Pelvic lipomatosis
Pemphigus
Pemphigus
Pemphigus
Pendred syndrome
Periarteritis nodosa
Perinatal infections
Periodontal disease
Peripartum cardiomyopathy
Peripheral neuropathy
Peritonitis
Periventricular leukomalacia
Pernicious anemia
Perniosis
Persistent sexual arousal...
Pertussis
Pes planus
Peutz-Jeghers syndrome
Peyronie disease
Pfeiffer syndrome
Pharmacophobia
Phenylketonuria
Pheochromocytoma
Photosensitive epilepsy
Pica (disorder)
Pickardt syndrome
Pili multigemini
Pilonidal cyst
Pinta
PIRA
Pityriasis lichenoides...
Pityriasis lichenoides et...
Pityriasis rubra pilaris
Placental abruption
Pleural effusion
Pleurisy
Pleuritis
Plummer-Vinson syndrome
Pneumoconiosis
Pneumocystis jiroveci...
Pneumocystosis
Pneumonia, eosinophilic
Pneumothorax
POEMS syndrome
Poland syndrome
Poliomyelitis
Polyarteritis nodosa
Polyarthritis
Polychondritis
Polycystic kidney disease
Polycystic ovarian syndrome
Polycythemia vera
Polydactyly
Polymyalgia rheumatica
Polymyositis
Polyostotic fibrous...
Pompe's disease
Popliteal pterygium syndrome
Porencephaly
Porphyria
Porphyria cutanea tarda
Portal hypertension
Portal vein thrombosis
Post Polio syndrome
Post-traumatic stress...
Postural hypotension
Potophobia
Poxviridae disease
Prader-Willi syndrome
Precocious puberty
Preeclampsia
Premature aging
Premenstrual dysphoric...
Presbycusis
Primary biliary cirrhosis
Primary ciliary dyskinesia
Primary hyperparathyroidism
Primary lateral sclerosis
Primary progressive aphasia
Primary pulmonary...
Primary sclerosing...
Prinzmetal's variant angina
Proconvertin deficiency,...
Proctitis
Progeria
Progressive external...
Progressive multifocal...
Progressive supranuclear...
Prostatitis
Protein S deficiency
Protein-energy malnutrition
Proteus syndrome
Prune belly syndrome
Pseudocholinesterase...
Pseudogout
Pseudohermaphroditism
Pseudohypoparathyroidism
Pseudomyxoma peritonei
Pseudotumor cerebri
Pseudovaginal...
Pseudoxanthoma elasticum
Psittacosis
Psoriasis
Psychogenic polydipsia
Psychophysiologic Disorders
Pterygium
Ptosis
Pubic lice
Puerperal fever
Pulmonary alveolar...
Pulmonary hypertension
Pulmonary sequestration
Pulmonary valve stenosis
Pulmonic stenosis
Pure red cell aplasia
Purpura
Purpura, Schoenlein-Henoch
Purpura, thrombotic...
Pyelonephritis
Pyoderma gangrenosum
Pyomyositis
Pyrexiophobia
Pyrophobia
Pyropoikilocytosis
Pyrosis
Pyruvate kinase deficiency
Uveitis
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Read more at Wikipedia.org


[List your site here Free!]


Persistent Thrombosis In A Case Of Paroxysmal Nocturnal Hemoglobinuria With Heparin Induced Thrombocytopenia - PNH - HIT
From CHEST, 10/1/00 by Amerlon Enriquez

Amerlon Enriquez MD, M. Kapoor MD--Memorial Sloan Kettering Cancer Center, New York, NY USA

Introduction: PNH is first described by William Gull in 1866 and is characterized by paroxysms of intravascular hemolysis and venous thrombosis. HIT is a relatively new disease first described by Weisman and Tobin in 1958 and is a common cause of immunologically mediated drug induced thrombocytopenia with a significant subset having thrombosis. We present the first reported case of PNH with associated HIT.

Case Presentation: Patient is a 31 y/o black woman who presented with hemoglobinuria and anemia. After extensive work-up, she was diagnosed with Paroxysmal Nocturnal Hemoglobinuria with flow cytometry that showed PNH III 20% and PNH II 4% in the red cells, and PNH phenotype in 90% of granulocytes. She was initially given steroids, which was tapered off and continued on aspirin and folate. A few months later she developed nausea, vomiting, and increasing abdominal girth over a few days. Pertinent findings include jaundice, distended abdomen with decreased bowel sounds and ascites. Significant tabs include Hgb 7, Hct 24, platelets 22, BUN 14, creatinine 1.3, total bilirubin 4.4, SGOT 214, alkaline phosphatase 214, and LDH 3670. Imaging studies of the abdomen, which includes ultrasound, CT scan, and MRI, showed Budd Chiari syndrome with thrombosis within inferior vena cava, main portal vein extending into the left portal vein and superior mesenteric vein, and thrombosis of all 3 hepatic veins. She was given alteplase (TPA) at 0.75 mg/kg infused over 24 hours and heparin IV infusion post TPA. She received a second dose of TPA at 0.75 mg/kg and a third dose at 1 mg/kg as follow-up imaging studies did not show significant change in her intraabdominal thrombosis. The third course of TPA however was not completed (received 65% of the dose), due to expansile hematoma in the right wrist from an arterial stick. Heparin was continued.

Two days later, patient had a change in mental status and MRI of the head showed thrombosis of the superior sagittal, right transverse and sigmoid sinuses and proximal right jugular vein and an abdominal ultrasound also showed progression of thrombosis in the main portal vein. She was given another dose of TPA at 0.8 mg/kg. The patient was then diagnosed with HIT with platelets decreasing to as low as 42000, with a positive HIT antibody. Heparin was discontinued and hirudin was initiated. A day after the last TPA infusion, a repeat MRI of the abdomen showed resolution of thrombus in the IVC, right hepatic vein and superior mesenteric, vein. During the course of the day however, the patient complained of headaches and noted to have increasing lethargy. Head CT showed bilateral subdural hematoma, left larger than right, with marked subfalcine and transtentorial herniation. Due to increasing lethargy patient was intubated and the left subdural hematoma was evacuated via burr hole. The patient's mental status improved and was later on extubated. Hirudin was subsequently restarted. Repeat imaging studies documented improvement in the intraabdominal thrombosis, however there was progression of cerebral venous thrombosis with worsening mental status. The patient was transferred to another institution for possible interventional thrombolysis of dural sinus thrombosis where she expired after a few days.

Discussion: More than half the patients with PNH tend to have thrombosis of the hepatic, portal, splenic, cerebral and other veins. The recommended therapy in such eases is anticoagulation with heparin and use of thrombolytics. Heparinoids are recommended in cases where heparin cannot be used. Patients with HIT can have arterial thrombosis but are more commonly associated with venous thrombosis. We present a case of PNH who was given repeated doses of TPA for Budd Chiari syndrome. Between TPA infusions she was anticoagulated with heparin till she developed HIT at which point hirudin was used. Even though the hepatic venous thrombosis improved her disease progressed and she developed cerebral venous thrombosis and expired. It is unclear from the case whether progression of the disease is from PNH itself, or failure of thrombolytics/anticoagulants, or if there was an associated component of HIT associated thrombosis along with PNH. Addition of glycoprotein IIb/IIIa inhibitor to hirudin was deferred due to increased bleeding tendency in a patient who already had subdural hematomas.

Conclusion: PNH associated with HIT can run a more complicated and persistent course and requires early initiation of hirudin. We are not sure whether a trial of Glycoprotein IIb/IIIa inhibitors could have altered the course.

COPYRIGHT 2000 American College of Chest Physicians
COPYRIGHT 2001 Gale Group

Return to Portal vein thrombosis
Home Contact Resources Exchange Links ebay